Personalized drug screening on horizon for multiple myeloma patients
A personalized method for testing the effectiveness of drugs that treat
multiple myeloma may predict quickly and more accurately the best
treatments for individual patients with the bone marrow cancer. The
process, developed by scientists at Washington University School of
Medicine in St. Louis, also may aid patients